MSA is excited to provide Australia with the only Subcutaneous Engineered Stabilization Device (ESD) that meets the 2016 Infusion Therapy Standards of Practice. The Standards state that subcutaneous ESDs have been successful in stabilizing PICCs and CVADs, and SecurAcath eliminates medical adhesive-related skin injury (MARSI).
SecurAcath provides improved catheter securement for the life of the line.
SecurAcath:
Please click here for more information.